1. 138 Phase 1 dose-escalation study of STRO-002, an anti-folate receptor alpha (FRα) antibody drug conjugate (ADC), in patients with advanced platinum-resistant/refractory epithelial ovarian cancer (OC). (13th November 2020) Authors: Naumann, R; Braiteh, F; Diaz, J; Hamilton, E; Diab, S; Schilder, R; Moroney, J; Martin, L; Uyar, D; O'Malley, D; Penson, R; DiLea, C; Palumbo, M; DeAlmeida, V; Berman, C; Matheny, S; Molina, A Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 3 Page Start: A61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 13 Efficacy on individualized starting dose (ISD) and fixed starting dose (FSD) of niraparib per investigator-assessment (IA) in newly diagnosed advanced ovarian cancer (OC). (13th November 2020) Authors: Graybill, W; Mirza, M; González-Martin, A; O'Malley, D; Gaba, L; Yap, OWS; Guerra, E; Rose, PG; Baurain, J; Ghamande, S; Denys, H; Prendergast, E; Pisano, C; Follana, P; Braicu, EI; Calvert, PM; Korach, J; Li, Y; Gupta, D; Monk, BJ Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 3 Page Start: A10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1721f Stronger together – working together to tackle the occupational hygiene void. (24th April 2018) Authors: Smedbold, HT; McClellan, N; Laszcz-Davis, C; Leibowitz, A; O´Donnell, L; Leeson, SJ; Di Corleto, R; Tresider, N; O'Malley, D Journal: Occupational and environmental medicine Issue: Volume 75(2018)Supplement 2 Page Start: A95 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 358 Phase 3 trial of tumor treating fields concomitant with weekly paclitaxel for platinum-resistant ovarian cancer: ENGOT-ov50/GOG-329/INNOVATE-3. (13th November 2020) Authors: Vergote, I; Salutari, V; Cibula, D; Korach, J; Samartzis, EP; Sehouli, J; Fossati, R; Martin, AG; Tsibulak, I; Slomovitz, B; Coleman, R; Monk, B; Thaker, P; O'Malley, D Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 3 Page Start: A147 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 76 Patients (PTS) with recurrent gynecologic cancer whose tumors have activating wnt pathway mutations respond better to DKN-01, a DICKKOPF-1 (DKK1) inhibitor. (18th September 2019) Authors: Arend, R; Castro, C; Matulonis, U; Hamilton, E; Gunderson, C; LyBarger, K; Goodman, H; Duska, L; Mahdi, H; ElNaggar, A; Kagey, M; Barroilhet, L; Bradley, W; Sachdev, J; O'Malley, D; Sirard, C; Birrer, M Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 3 Page Start: A40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P154 Tumor treating fields (200 kHz) concomitant with weekly paclitaxel for platinum-resistant ovarian cancer: phase 3 INNOVATE/ENGOT-ov50 study. (1st November 2019) Authors: Vergote, I; Copeland, L; Monk, B; Coleman, R; Cibula, D; Sehouli, J; Samartzis, EP; Madry, R; González Martin, A; Korach, J; Salutari, V; Witteveen, PO; O'Malley, D Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 4 Page Start: A152 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Radiotherapy instead of inguinofemoral lymphadenectomy in vulvar cancer patients with a metastatic sentinel node: results of GROINSS-V II. (1st November 2019) Authors: Oonk, MHM; Slomovitz, B; Baldwin, P; van Doorn, H; van der Velden, J; de Hullu, J; Slangen, B; Gaarenstroom, K; Vergote, I; Brannstrom, M; van Dorst, E; van Driel, W; Hermans, R; Nunns, D; Widschwendter, M; Nugent, D; Holland, C; DiSilvestro, P; Sharma, A; Mannel, R Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 4 Page Start: A14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗